DionyMed Brands Inc. Provides 1st Quarter 2019 Business Update
TORONTO, May 1, 2019–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed”, “DYME” or “Company”) (CSE: DYME) (OTC: DYMEF), a multi-state cannabis brands, distribution and direct-to-consumer delivery platform, announced today the following financial and operational update for its first fiscal quarter of 2019.
First Quarter 2019 Financial Highlights
- Record setting preliminary gross revenue of US$14.2 million, representing 155% growth over the fourth quarter of 2018, from distribution and direct-to-consumer sales of house and third-party brands.
- Gross margins expanded to 45%, or approximately US$6.4 million, from 36%, or approximately US$2.0 million, representing 25% growth from gross margins realized in the fourth quarter of 2018, due to an increase in the share of house brand products sold and direct-to-consumer delivery.
- The Company continues to improve its gross margins and platform efficiency to reduce costs and improve its EBITDA.
- An additional US$5.0 million wholesale value of product was delivered through the Company’s wholesale logistics business for third-party brands. The wholesale logistics business recognizes net revenue rather than the full wholesale value of product distributed by the Company. Total combined gross sales of product from the Company were US$19.2 million.
First Quarter 2019 Operational Highlights
Expansion of DYME’s Award Winning Cannabis Brands Portfolio
- DYME house brand “Winberry Farms” exceeded US$1.0 million of wholesale revenue during the month of March.
- DYME house brand “Gardener’s” was launched in Oregon, expanding house brand sales outside of California.
- Launched twelve CBD-focused products under DYME’s award-winning brand, Winberry Farms.
- DYME house brands represented more than 50% of wholesale distribution revenue in March accelerating product sales margin expansion.
Expansion of “Chill”, DYME’s Direct-To-Consumer Delivery Platform
- DYME expanded the “Chill” Bay Area delivery territory to include San Francisco, Hayward, Fremont and Cupertino in response to favorable changes in California’s direct-to-consumer regulations.
- Enhanced the Chill product offering adding more than 150 SKUs, including products from award winning brands, like Winberry Farms, Gardener’s, Dosist, Kiva, Canndescent, Plus Products and PAX.
- Relaunched the Chill online user experience driving new user adoption, revenue growth and margin expansion.
Expansion into New Markets
- Announced a strategic product manufacturing and distribution partnership with Acres Cannabis, which, was recently acquired by Curaleaf. As a result, DYME brands are now available in select cannabis retail dispensaries in Las Vegas, Nevada.
- Signed a binding term sheet to acquire a 1.83 acre Los Angeles cannabis campus with 80,000 sq ft that includes 80,000 sq ft of retail dispensary storefront, distribution, manufacturing space and direct-to-consumer fulfillment. The transaction is scheduled to close on May 31, 2018 with a combination of equity and real estate financing, as previously disclosed.
- Signed a definitive agreement to acquire Pioneer Valley Extracts, LLC, a licensed product manufacturer in Massachusetts. The transaction was done with equity and nominal cash, as previously disclosed.
We are pleased to report our progress in the first quarter of 2019, demonstrating the success of our wholesale distribution and direct-to-consumer platform strategy.
Edward Fields, CEO of DionyMed
DYME’s award winning house brands have become one of the industry’s fastest growing cannabis product portfolios driving increased sales and accelerating margin expansion. Chill, DYME’s direct-to-consumer delivery offering, is experiencing explosive growth following the relaunch of the online ecommerce website with a record setting performance during 4/20 and thousands of new customers.
Fields concluded, “Moving forward in 2019, we will continue to scale our business through focused execution, accretive inorganic growth and the infrastructure buildout required by our market leading scale. As favorable direct-to-consumer regulations in California and across the U.S. expand, we look forward to bringing our award-winning brands, market leading ecommerce technology and logistics to consumers throughout California and beyond.”
Effective December 5, 2018, when the Company announced the exercise of its option to acquire all the shares of Hometown Heart (the “Hometown Shares”) and the subsequent completion of the acquisition on December 13, 2018, the Company transferred all of the Hometown Shares to a single individual who was a former owner of shares of Hometown in consideration for the grant of an irrevocable option (the “Option”) to re-acquire the Hometown Shares for a nominal amount following the receipt of all required regulatory approvals. In connection with the foregoing, the Company’s subsidiary Herban Industries, Inc. (“Herban”) and Hometown Heart entered into a Master Services Agreement pursuant to which Herban exercises control over Hometown Heart and provides Hometown Heart with management, labor administration, marketing, branding, professional, banking, record-keeping, intellectual property, governance, and other support services. The Company has consolidated the accounts of Hometown Heart in its consolidated financial accounts since December 13, 2018 as a result of the Master Services Agreement and the Option.
All financial disclosures in this press release are preliminary and subject to change upon the financial statements for the quarter ended March 31, 2019 being finalized and filed. Annual revenue run-rates assume that revenues being annualized are representative and will be achieved in future periods.
To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.
Founded in 2017, DionyMed is a multi-state cannabis brands platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves cannabis consumers through retail dispensary distribution and direct-to-consumer fulfillment with its growing portfolio of award-winning brands. Learn more at dionymed.com and follow @DYME_Inc on Twitter and LinkedIn.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.